Thursday, 13 December 2018

Awareness on Hepatitis C


Awareness on Hepatitis C


                           


How do we get Hepatitis C?


                                                  A syringe with blood on the end tip. Needle pricks can cause hepatitis c (hep c) infection.
Hepatitis C is a blood-borne illness, meaning it is transmitted via contact with infected blood. Usually the virus enters the body through a puncture wound on the skin.

Hepatitis C symptoms:

          

About 70% to 80% of people with the hepatitis C virus do not have any symptoms, especially in the early stages. In these people, symptoms may develop years, even decades later, when liver damage occurs. Others develop symptoms between 2 weeks to 6 months after infection. The average time to develop symptoms is 6 to 7 weeks after acquiring the virus. A person who has hepatitis C infection, but isn't exhibiting any symptoms can still pass the virus on to others. Hepatitis C symptoms may include:
  • Mild-to-severe fever
  • Fatigue
  • Abdominal pain
  • Loss of appetite
  • Nausea
  • Vomiting
  • Joint pain
  • Dark urine
  • Clay-colored stool
  • Yellowing of the skin (jaundice)

Hepatitis c testing:

                                            

If you have any risk factor for hepatitis C,
Then the next step is to test for it. Initial testing for hepatitis C has three parts: 

The first test:
 The HCV antibody test sees if you have been exposed to the virus.

The second test:
 The viral load test and it detects whether you were merely exposed or if you actually have hep C. If that test is positive,

The third test:
Genotype test is done to find out what kind of hep C you have. 

HCV Antibody Testing: Diagnosing hepatitis C begins with an antibody test. Antibodies to HCV can be detected in the blood, usually within two or three months after the virus enters the body. If a person is positive for HCV antibodies, he or she has been exposed to the virus in the past. About 15 to 25 % of people who are initially infected with HCV are able to clear the virus from their bodies, usually within six months of exposure. The next step is to look for the actual virus in the bloodstream, using a viral load test. If a person has an acute infection, meaning that he or she was recently infected with HCV, antibodies may not have formed yet, so a viral load is necessary to confirm infection.

HCV Viral Load Testing: A health care provider can request a qualitative HCV RNA test to determine if the virus is in a person’s bloodstream. A medical provider can also order a quantitative HCV RNA test to figure out a person’s HCV viral load (the amount of HCV in a measurement of blood). Various methods are used to detect HCV RNA, including TMA (transcription-mediated amplification), PCR (polymerase chain reaction), and bDNA (branched DNA). Qualitative viral load testing tends to be more sensitive than quantitative testing. Viral load testing using PCR or TMA are more sensitive than bDNA testing. 

HCV viral load testing is used during treatment to determine how well the medications are working. Increases and decreases in HCV RNA do not correlate to disease progression, so the qualitative viral load test is not very useful outside of treatment. HCV viral load results cannot determine if or when someone with hepatitis C will develop cirrhosis or liver failure.

HCV Genotypic Testing: Genotype refers to the genetic structure or makeup of living organisms. The hepatitis C virus has eight different genotypes, which are numbered in the order of their discovery. (The identification of genotype 8 was announced at the 2017 Liver Meeting.) Each of these genotypes has subtypes, which were lettered in the order that they were discovered. It is important to find out which hepatitis C genotype you have, because it determines the best treatment for you. HCV genotype also helps to predict the likelihood of curing HCV, but improved medications with high cure rates have made this less useful. 

Worldwide, HCV genotype 1 is most common, accounting for 46 % of cases. In the United States, 75 % of all HCV infections are genotype 1; genotypes 2, 3 and 4 are less common in the United States, and other genotypes are rare. Genotype 7 was discovered in 2013 and there is only one known case. Two genotype 8 cases were identified in India. It is possible to infected with more than one HCV genotype; this most likely occurs among injection drug users, and people who received contaminated blood products before 1987 (when viral inactivation started), or a blood transfusion before July 1992 (when effective screening procedures were instituted).
To learn more or globalize your research in international wide, Join with our international conference.


Hepatitis 2019 Conference Info: 

7th International Conference on Hepatitis and Liver Diseases (Hepatitis 2019) to be held in London, UK during May 02-03, 2019. The conference highlights the theme “Raising awareness and advancement towards Hepatitis and Liver Diseases”.
The conference invites Hepatologists, Gastroenterologists, Virologists, Microbiologists, immunologist, Pathologists, Oncologists, Toxicologists, Researchers, Students, Young researchers and business delegates across the World.
Hepatitis 2019 Conference is to bring top experts together and delegates for an in-depth discussion on Hepatitis and Liver diseases. To create awareness for both rural and urban population about liver disease it should be diagnosed at early stages. The importance of this conference is to update, clinically relevant audience regarding the evidence supporting current clinical practices in hepatitis. The information presented is intended to enhance clinical competence in the diagnosis and treatment of hepatitis and liver disease.

      Conference Highlights


#Christmas Offer 

20% discount on Registration
Use the discount code : XMAS20

With regards
Joseph Raven
Conference manager | Hepatitis 2019


#Christmas #HepatitisC #LondonConference #Europe #MedicalConference #Publicawareness #Education #Knowledge 

Saturday, 3 November 2018

Viral Hepatitis

Viral Hepatitis


Hepatitis B virus

Hepatitis B is an infectious disease which causes inflammation in the liver. Hepatitis B is caused by Hepatitis virus (HBV). For some of the people, Hepatitis B became chronic; it means the symptoms last more than 6 months. Due to long lasting symptoms of this virus it may causes risk to the liver and causes certain disease like liver damage i.e liver cancer or liver cirrhosis which causes permanent scar of the liver. Most of the adult those who are suffering from Hepatitis B virus get cured even they have sign and symptoms in severe. But infant and children those who are suffering from HBV have more likely to develop a Chronic Hepatitis B infection. HBV can survive outside at least for 7days still the virus have the ability to cause the infection. A vaccine can prevent from hepatitis infection.
But there is no such cure for the person those who already in the condition. If you are infected then you can only prevent by taking certain precautions for the spreading the virus to the others.
Pathogenesis and clinical manifestation of Hepatitis B is due to interaction of HBV and host immune system, which leads to liver damage, liver cancer or liver cirrhosis and hepatocellular carcinoma .


Hepatitis A,B&D Virus

Now a days hepatitis A is a commonly causing viral disease which causes inflammation in the liver. It is caused by hepatitis A virus. It is a short term disease that will not develop to the chronic disorder. This virus is transmitted from one person to another through faecal-oral infection (food or drinks that has been contaminated with stool of a person who already affected by this virus) . HAV commonly spread in those areas where poor sanitary conditions or where good personal cleanliness is not observed well.
 It is additionally referred to as delta virusHDV(Hepatitis D virus) is an RNA virus it needs hepatitis B virus to replicate. HDV causes illness only in those patients who have the hepatitis B virus. Transmission happens through infected blood, needles, or sexual contact from an infected person. HDV infection can be prevented by the hepatitis B vaccine and avoiding those activities that results in attain this virus. Those that don’t seem to be vaccinated to HBV square measure in danger of obtaining this viral disease that result in cause hepatitis D.
Hepatitis E is an infectious disease which causes inflammation in the liver. It is caused by hepatitis E virus. According to resent survey 20 million cases of hepatitis E infection are been registered. and 44,000 of these cases resulted in death. It is more common in developing countries. Hepatitis E usually resolves by itself, but may develop into acute liver failure.

Hepatitis C virus
Hepatitis C is the viral infectious disease which causes inflammation in the liver. It can be either acute or chronic. Hepatitis C caused by the Hepatitis C virus (HCV). HCV can be transferred by exposure to infected blood, intravenous drug abuse with the use of contaminated. Some people who experience the hepatitis C virus for short time (up to six months) and then they get better on their own.  This is called acute Hepatitis C.  But most of the people (around 75% – 85%) will go on to develop chronic (long-term) Hepatitis C, it means doesn’t go away. Worldwide, viral hepatitis kills more than one million people each year, and more than 350 million people are chronically infected with Hepatitis C. Hepatitis C virus doesn’t show any symptoms or very mild symptoms in the early stage. Many people don’t have an idea that they are suffering from hepatitis c virus until liver damage show up. Sometimes they get to know by routine medical testing. The recent significant advancements in treating hepatitis C build-up the improvements over the previous two decades to transform hepatitis C from a chronic, fatal disease, to an infection that with new and upcoming treatments, can be potentially cured.

To know more about the viral hepatitis  attend our upcoming 7th international conference on Hepatitis and Liver Diseases (Hepatitis 2019) scheduled to be held on May 02-03, 2019 in London, UK.
The conference highlights the theme “Raising awareness and advancement towards Hepatitis and Liver Diseases”.


The conference invites Hepatologists, Gastroenterologists,Virologists,Microbiologists, immunologist
Pathologists,Oncologists,Toxicologists,Researchers,Students,Young researchers and business delegates across the World.
Hepatitis 2019 Conference is to bring top experts together and delegates for an in-depth discussion on Hepatitis and Liver diseases. To create awareness for both rural and urban population about liver disease it should be diagnosed at early stages. The importance of this conference is to update, clinically relevant audience regarding the evidence supporting current clinical practices in hepatitis. The information presented is intended to enhance clinical competence in the diagnosis and treatment of hepatitis and liver disease.
In the meantime, please check out our 
website for more details: https://hepatitis.euroscicon.com
Joseph Raven
Program Director | Hepatitis 2019
Email: hepatitisconference@yandex.com

whats app us : +44238214671
Facebook : https://www.facebook.com/2018hepatitis


Friday, 21 September 2018

The 10 Best Things to Do and Visit London



7th International Conference on Hepatitis and Liver Diseases.
We are honoured to invite you to the “7th International Conference on Hepatitis and Liver Diseases” (Hepatitis 2019) to be held in London, UK during May 02-03, 2019. The conference highlights the theme “Raising awareness and advancement towards Hepatitis and Liver Diseases”.
Hepatitis 2019 Conference is to bring top experts together and delegates for an in-depth discussion on Hepatitis and Liver diseases. To create awareness for both rural and urban population about liver disease it should be diagnosed at early stages. The importance of this conference is to update, clinically relevant audience regarding the evidence supporting current clinical practices in hepatitis. The information presented is intended to enhance clinical competence in the diagnosis and treatment of hepatitis and liver disease.
For more details visit our  WEBSITE LINK:- https://hepatitis.euroscicon.com/

About the destination: London
London, the capital city of United Kingdom, stands on the River Thames and is located southeast
Of the island of Great Britain. London covers an area of 1579 square kilometres and according to
2016 statistics, Greater London’s population was estimated to be 8.63 million.
London is a leading global city excelling in the fields of arts, commerce, education, entertainment,
Fashion, finance, healthcare, media, professional services, research and development, tourism,
and transportation. As the world’s largest financial centre, London serves as an attractive
destination for international investors and businessmen. The headquarters of important banks
like HSBC, Royal Bank of Scotland, Barclays and Standard Chartered are located here. The city
has the World’s largest city airport. If we look at the cultural distribution of the city, London is often
described as a cultural hub. It is home to a wide variety of people from different backgrounds and
more than 300 languages are spoken. The host city also has some of the best medicine schools
like The Imperial College London, the University College London, The King’s College London,
Queen Mary’s University of London and St. George’s University of London. Funds for research are
available from Research Councils, National Institutes of Health, European Commission, other UK
Government Departments and also from commercial sectors like private companies. In 2016, the
idea of a global research hub in London was put forward, to bring over ten thousand scientists and
clinical researchers together in order to accelerate advancements in cancer science.
The Buckingham Palace, Tower of London, BigBen, the Madame Tussauds wax museum,
Westminster Abbey, and the London Eye are important tourist destinations in this city.


                   Buckingham Palace



                             Big Ben


                           
                         London Eye


                           
                   
                    Tower of London

Regards,
Joseph Raven
Hepatitis 2019
Email:- hepatitisconference@yandex.com

Thursday, 6 September 2018

CME/CPD Accredited | 7th International Conference on Hepatitis and Liver Diseases. | May 02-03,2019 | London, UK


We are honoured to invite you to the 7th International Conference on Hepatitis and Liver Diseases (Hepatitis 2019) to be held in London, UK during May 02-03, 2019. The conference highlights the theme “Raising awareness and advancement towards Hepatitis and Liver Diseases”.
The conference invites Hepatologists, Gastroenterologists,Virologists,Microbiologists,
Pathologists,Oncologists,Toxicologists,Researchers, Students,Young researchers and business delegates across the World.
Hepatitis 2019 Conference is to bring top experts together and delegates for an in-depth discussion on Hepatitis and Liver diseases. To create awareness for both rural and urban population about liver disease it should be diagnosed at early stages. The importance of this conference is to update, clinically relevant audience regarding the evidence supporting current clinical practices in hepatitis. The information presented is intended to enhance clinical competence in the diagnosis and treatment of hepatitis and liver disease.
Conference website:-https://hepatitis.euroscicon.com/
      Conference Highlights

Friday, 6 July 2018

7th intenational conference on Hepatitis and Liver DIseases

7th international conference on Hepatitis and Liver Diseases

About Conference

EuroSciCon invites you to attend 7th international conferences on Hepatitis and Liver diseases (Hepatitis 2019) to be held in London, UK during May 02-04, 2019. The conference highlights the theme “Raising awareness and advancement towards Hepatitis and Liver Diseases”.

The event offers a best platform with its well organized scientific program to the audience which includes symposiums, workshops, keynote lectures, plenary talks, panel discussions and poster sessions on latest research and technological developments in the arena as well as therapeutic aspects. The conference invites Hepatologists, Gastroenterologists, Internists, Physicians, Microbiologists, Virologists, Pathologists, Oncologists, Surgeons, Toxicologists, Researchers, Students, Business delegates and Young researchers across the globe.

Euroscicon organizes 600+ International Conferences Every Year across USA, Europe & Asia with support from 1200 more scientific Societies and publishes 700+ Open Access Journals which contains over 30000 eminent personalities, reputed scientists as editorial board members.


Scope of Conference

Hepatitis 2019 provides a great platform by gathering eminent professors, Researchers, Students and delegates to exchange new ideas.  The conference will cover a wide range of topics and allow participants to discuss about the management of liver diseases. Hepatitis 2019 conference consists of keynote and plenary lectures, special sessions (Workshop and Symposium), Young Researcher Forum and Poster presentations. Best poster presenters will be judged and awarded during the conference. To encourage broad participation from all over the world EuroSciCon is offering reduced registration fee for students.

Conference Highlights



Special Issues

All accepted abstracts will be published in respective Conference Series Journals.
 Abstracts will be provided with Digital Object Identifier by Cross Ref.